Hemab Therapeutics prices IPO at $18 per share
SWI Editorial Staff2026-04-30T16:07:03-07:00Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...









